# Commission Implementing Regulation (EU) No 677/2014 of 19 June 2014 amending Regulation (EU) No 37/2010, as regards the substance ‘cabergoline’ (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order:
Pharmacologically active Substance
Marker residue
Animal Species
MRL
Target Tissues
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic Classification
‘Cabergoline
Cabergoline
Bovine
0,10 μg/kg
Fat
NO ENTRY
Prolactin inhibitor’
0,25 μg/kg
Liver
0,50 μg/kg
Kidney
0,15 μg/kg
Muscle
0,10 μg/kg
Milk

---
Source: https://www.legislation.gov.uk/eur/2014/677/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-677/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.